WO1996002272A3 - Treatment of autoimmune diseases - Google Patents

Treatment of autoimmune diseases Download PDF

Info

Publication number
WO1996002272A3
WO1996002272A3 PCT/EP1995/002885 EP9502885W WO9602272A3 WO 1996002272 A3 WO1996002272 A3 WO 1996002272A3 EP 9502885 W EP9502885 W EP 9502885W WO 9602272 A3 WO9602272 A3 WO 9602272A3
Authority
WO
WIPO (PCT)
Prior art keywords
host
autoimmune diseases
preventing
treatment
infecting
Prior art date
Application number
PCT/EP1995/002885
Other languages
French (fr)
Other versions
WO1996002272A2 (en
Inventor
Erna Moeller
Cecilia Soederberg
Original Assignee
Erna Moeller
Cecilia Soederberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erna Moeller, Cecilia Soederberg filed Critical Erna Moeller
Priority to AU31637/95A priority Critical patent/AU3163795A/en
Priority to EP95927691A priority patent/EP0773793A1/en
Publication of WO1996002272A2 publication Critical patent/WO1996002272A2/en
Publication of WO1996002272A3 publication Critical patent/WO1996002272A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Autoimmune diseases such as graft versus host disease, are associated with the development of an autoimmune response, such as autoantibodies raised against a host protein carried by an infecting microorganism. The invention provides methods of combatting autoimmune diseases by preventing the organism from infecting the host, by vaccination, by preventing the antibodies from effecting tissue damage, and by preventing the organisms from initiating an immune response in the host. The invention includes modified microorganisms which either lack the host protein or in which the host protein is non-immunogenic.
PCT/EP1995/002885 1994-07-20 1995-07-20 Treatment of autoimmune diseases WO1996002272A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU31637/95A AU3163795A (en) 1994-07-20 1995-07-20 Treatment of autoimmune diseases
EP95927691A EP0773793A1 (en) 1994-07-20 1995-07-20 Treatment of autoimmune diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414652A GB9414652D0 (en) 1994-07-20 1994-07-20 Method of treatment
GB9414652.9 1994-07-20

Publications (2)

Publication Number Publication Date
WO1996002272A2 WO1996002272A2 (en) 1996-02-01
WO1996002272A3 true WO1996002272A3 (en) 1996-03-21

Family

ID=10758627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/002885 WO1996002272A2 (en) 1994-07-20 1995-07-20 Treatment of autoimmune diseases

Country Status (4)

Country Link
EP (1) EP0773793A1 (en)
AU (1) AU3163795A (en)
GB (1) GB9414652D0 (en)
WO (1) WO1996002272A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10934209B2 (en) 2016-10-13 2021-03-02 Corning Incorporated Glass-based articles having improved fracture performance

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334301A1 (en) * 1988-03-21 1989-09-27 Chiron Viagene, Inc. Recombinant retroviruses
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
US5252603A (en) * 1989-03-15 1993-10-12 Cetus Corporation Immunosuppressive analogues and derivatives of succinylacetone

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334301A1 (en) * 1988-03-21 1989-09-27 Chiron Viagene, Inc. Recombinant retroviruses
US5252603A (en) * 1989-03-15 1993-10-12 Cetus Corporation Immunosuppressive analogues and derivatives of succinylacetone
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JOHAN NEYTS ET AL.: "Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate", VIROLOGY, vol. 189, no. 1, pages 48 - 58 *
M. O. WESTENDORP ET AL.: "Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120", NATURE, vol. 375, pages 497 - 500 *
PENTTI UKKONEN: "Production of polyclonal antisera against cytomegalovirus and varicella-zoster virus by use of affinity-purified viral antigens", APMIS (ACTA PATHOL MICROBIOL IMMUNOL SCAND), vol. 97, no. 3, pages 267 - 273 *
TROND FLAEGSTAD ET AL.: "Inoculation with BK virus may break immunological tolerance to histone and DNA antigens", PROC. NATL. ACAD. SCI. USA, vol. 85, no. 21, pages 8171 - 8175 *

Also Published As

Publication number Publication date
EP0773793A1 (en) 1997-05-21
GB9414652D0 (en) 1994-09-07
WO1996002272A2 (en) 1996-02-01
AU3163795A (en) 1996-02-16

Similar Documents

Publication Publication Date Title
WO1996011279A3 (en) Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
WO1996010419A3 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
CA2381770A1 (en) Human ctla-4 antibodies and their uses
DE69529219D1 (en) Helicobacter proteine und impstoffe
HK1021025A1 (en) Process for in vitro detecting the presence or absence of antibodies to anti-tissue transglutinase from body fluids.
GEP20032977B (en) Proteinase K-Resistant Surface Protein of Neisseria Meningitidis
WO2000066067A3 (en) Ibd-associated microbial antigens and methods of using same
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
EP0400958A3 (en) Live vaccines
MXPA02011656A (en) Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
WO1998058965A3 (en) B7-binding molecules for treating immune diseases
AU2001285210A1 (en) Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
ZA965565B (en) Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits.
EP0712926A3 (en)
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
EP1354599A3 (en) Pharmaceutical or food composition for treating pathologies related to graft versus host
WO1996002272A3 (en) Treatment of autoimmune diseases
EP1028754A4 (en) Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
WO1997046253A3 (en) Immunotherapy for autoimmune disease
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
WO1998051782A3 (en) Human 3-hydroxyisobutyryl-coenzyme a hydrolase
EP0780472A3 (en) Stress proteins
BR0016616A (en) Attenuated microorganisms for the treatment of infection
WO1998023752A3 (en) Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1995927691

Country of ref document: EP

ENP Entry into the national phase

Ref country code: US

Ref document number: 1997 776012

Date of ref document: 19970314

Kind code of ref document: A

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1995927691

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1995927691

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1995927691

Country of ref document: EP